Validation of HPLC, DPPH• and nitrosation methods for mesalamine determination in pharmaceutical dosage forms

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 43, Issue 1, 2007, Pages 97-103

  Rafael, Janice Aparecida ^a   Jabor, José Roberto ^a   Casagrande, Rúbia ^a   Georgetti, Sandra Regina ^a   Borin, Maria De Fátima ^a   Fonseca, Maria José Vieira ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

1,1 diphenyl 2 picrylhydrazyl radicals; High performance liquid chromatography; Mesalamine; Nitrosation; Pharmaceutical dosage forms; Validation

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ALCOHOL; ASALIT; BUFFER; MESALAZINE; METHANOL; SODIUM NITRITE; TETRABUTYLAMMONIUM; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; DRUG DOSAGE FORM; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; NITROSATION; PH; QUALITY CONTROL; TABLET FORMULATION;

EID: 34249778663     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322007000100012     Document Type: Article

References (16)

1. ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS. Official Methods of Analysis. 15. ed. Arlington: Association of Official Analytical Chemists, 1990. v.1, p. 17.
2. ASSOCIATION OF OFFICIAL ANALYTICAL CHEMISTS. Statistical Manual of the AOAC. 12 ed. Washington: AOAC, 1975. p. 1094.
3. CAI, Q. X.; ZHU, K. J.; CHEN, D.; GAO, L. P. Synthesis, characterization and in vitro release of aminosalicylic acid and 5-acetyl aminosalicylic acid of polyanhydrine - P (CBFAS). Eur. J. Pharm. Biopharm., Amsterdam, v. 55, p. 203-208, 2003.
4. CENDROWSKA, I.; DREWNOSKA, A.; GRZESZKIEWICZ, A.; BUTKTEWICZ, K. Investigation of the stability of 5-aminosalicylic acid in tablets and suppositories by high-performance liquid chromatography. J. Chromatogr., Amsterdam, v. 509, p. 195-199, 1990.
5. DINIS, T.C.P.; MADEIRA, V.M.C.; ALMEIDA, L.M. Action of phenolic derivatives (acetaminophen, salicylate and 5-aminosalicylate) as inhibitors membrane lipid peroxidation and peroxyl radical scavengers. Arch. Biochem. Biophys., New York, v. 315, n.1, p. 161-169, 1994.
6. GEIER, D.L.; MINER, P.B. New therapeutic agents in the treatment of inflammatory bowel disease. Am. J. Med., New York, v.93, n.2, p.208-298, 1992.
7. GOTTI, R.; POMPONIO R.; BERTUCCI, C.; CAVRINI, V. Determination of 5-aminosalicylic acid related impurities by micellar electrokinetic chromatography with an ion-pair reagent. J. Cromatogr. A, Amsterdam, v. 916, p. 175-183, 2001.
8. HANAUER, S.B. Inflammatory bowel disease revisited: Newer drugs. Scand. J. Gastroenterol., Oslo, v. 25, n. 175, p. 97-106, 1990.
9. HANEY, P.W.; DASH, A.K. Simple liquid chromatographic method for the analysis of 5-aminosalicylic acid and its degradation product. J. Chromatogr. A, Amsterdam, v.765, p. 233-238, 1997.
10. KOROLKOVAS, A. Análise farmacêutica. Rio de Janeiro: Guanabara Koogan, 1988. p.159.
11. MENDEZ, A.S.L.; STEPPE, M.; SCHAPOVAL, E.E.S., Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceuticcal dosage form. J. Pharm. Biomed. Anal., Oxford, v.33, p.947-954, 2003.
12. PALUMBO, G.; CARLUCCI, G.; MAZZEO, P. et al., Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic intestinal biopsy samples in humans by high-performance liquid chromatography with electrochemical detection. J. Pharm. Biomed. Anal., Oxford, v.14, p.175-180, 1995.
13. PAREJO, I.; CODINA, C.; PETRAKIS, C.; KEFALAS, P. Evaluation of scavenging activity assessed by Co (11)/EDTA-induced luminol chemiluminescence and DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical assay. J. Pharmacol. Toxicol. Methods, New York, v.44, p.507-512, 2000.
14. RAGGI, M.A.; CASAMENTI, G.; MANDRIOLI, R.; IZZO, G.; KENNDLER, E. Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry. J. Pharm. Biomed. Anal., Oxford, v.23, p. 973-981, 2000.
15. RILEY, S.A.; TURNBERG, L.A. Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease. Q. J. Med., Oxford, v.75, n.278, p. 551-562, 1990.
16. UNITED States Pharmacopeia 24. ed. Rockville, United States Pharmacopeial Convention, 2000. [CD-ROOM].